Fortis Therapeutics
About:
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.
Website: https://fortistx.com/
Top Investors: Lilly Asia Ventures, Vivo Capital, OUP (Osage University Partners), Avalon Ventures, Myeloma Investment Fund
Description:
Fortis Therapeutics is immuno-oncology biotech focused on developing new antibody-drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications.
Total Funding Amount:
$58M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
La Jolla, California, United States
Founded Date:
2016-01-01
Founders:
Bin Liu
Number of Employees:
51-100
Last Funding Date:
2021-03-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai